Clinical Trial Update: Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing Technosphere Insulin against Insulin Aspart in adults with Type 1 Diabetes Mellitus over a 24-week treatment period; results have been…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Insulin aspart (insulin aspart)
• Technosphere insulin (insulin inhalation)

Snippet

Sponsor: Mannkind Corporation | Conditions: Type 1 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2014-10-22